Loading
Latest filing published 24 Oct 2022 for BioPharma Credit PLC, €48k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Linda Davey discloses dealings in BioPharma Credit PLC to RNS (LSE). The record holds 2 filings, for trades running from 30 September 2020 to 24 October 2022.
No open-market sale appears; the market trades are 2 purchases worth €91k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 1 purchase and no sales.
Most recently, on 24 October 2022, the filings show an open-market purchase worth €48k in BioPharma Credit PLC. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 1 declaration